TEST BANK W
PHARMACOLOGY
CLEAR & SIMPLE:
W W
A Guide to Drug Classifications and Dosage Calculations
W W W W W W W
3RD EDITION| By: Cynthia J. Watkins
W W W W W
TEST BANK W
,TestWBank:WPharmacologyWClearWandWSimple:WAWGuideWtoWDrugWClassificationsWa
ndWDosageWCalculationsW3rdWEditionWbyWCynthiaWJ.WWatkins
TableWofWContents:
ChapterW1.WHistoryWofWPharmacology
ChapterW2.WBasicsWofWPharmacology
ChapterW3.WPatientWSafetyWinWMedicationWAdministration
ChapterW4.WRegulations
ChapterW5.WPrescriptionsWandWLabels
II.WCalculations
ChapterW6.WBasicWReviewWofWMathematic
sWChapterW7.WMeasurementWSystemsWCh
apterW8.WDosageWCalculations
ChapterW9.WEnteralWMedicationsWandWAdministration
ChapterW10.WParenteralWMedicationsWandWAdministration
ChapterW11.WIntegumentaryWSystemWMedications
ChapterW12.WMusculoskeletalWSystemWMedications
ChapterW13.WNervousWSystemWMedications
ChapterW14.WEyeWandWEarWMedications
ChapterW15.WEndocrineWSystemWMedications
ChapterW16.WCardiovascularWSystemWMedications
ChapterW17.WImmunologicalWSystemWMedications
ChapterW18.WPulmonaryWSystemWMedications
ChapterW19.WGastrointestinalWSystemWMedications
ChapterW20.WReproductiveWandWUrinaryWSystemsWMedications
ChapterW21.WHerbs,WVitamins,WandWMinerals
,ChapterW1.W HistoryW ofW Pharmacology
PharmacologyWClearWandWSimple-
WAWGuideWtoWDrugWClassificationsWandWDosageWCalculationsW3rdWEditionWWatkinsWTestWBank
1.
AWnurseWworkingWinWradiologyWadministersWiodineWtoWaWpatientWwhoWisWhavingWaco
mputedWtomographyW(CT)Wscan.WTheWnurseWworkingWonWtheWoncologyWunitWadminister
sWchemotherapyWtoWpatientsWwhoWhaveWcancer.WAtWtheWPublicWHealthDepartment,WaWnu
rseWadministersWaWmeasles-mumps-rubellaW(MMR)WvaccineWtoWaW14-month-
oldWchildWasWaWroutineWimmunization.WWhichWbranchWofWpharmacologyWbestWdescribes
WtheWactionsWofWallWthreeWnurses?
A) Pharmacoeconomics
B) Pharmacotherapeutics
C) Pharmacodynamics
D) Pharmacokinetics
Ans: B
Feedback:
PharmacologyWisWtheWstudyWofWtheWbiologicWeffectsWofWchemicals.WNursesWareWinvolve
dWwithWclinicalWpharmacologyWorWpharmacotherapeutics,WwhichWisWaWbranchWofWphar
macologyWthatWdealsWwithWtheWusesWofWdrugsWtoWtreat,Wprevent,WandWdiagnoseWdisease.
WTheWradiologyWnurseWisWadministeringWaWdrugWtoWhelpWdiagnoseWaWdisease.WTheWonco
logyWnurseWisWadministeringWaWdrugWtoWhelpWtreataWdisease.WPharmacoeconomicsWincl
udesWanyWcostsWinvolvedWinWdrugWtherapy.PharmacodynamicsWinvolvesWhowWaWdrugWa
ffectsWtheWbodyWandWpharmacokineticsWisWhowWtheWbodyWactsWonWtheWbody.
2.
AWphysicianWhasWorderedWintramuscularW(IM)WinjectionsWofWmorphine,WaW
narcotic,WeveryW4WhoursWasWneededWforWpainWinWaWmotorWvehicleWaccidentW
victim.WTheWnurseWisWawareWthisWdrugWhasWaWhighWabuseWpotential.WUnderW
whatWcategoryWwouldWmorphineWbeWclassified?
A) ScheduleWI
B) ScheduleWII
C) ScheduleWIII
D) ScheduleWIV
Ans: B
, Feedback:
NarcoticsWwithWaWhighWabuseWpotentialWareWclassifiedWasWScheduleWIIWdrugsW
becauseWofWsevereWdependenceWliability.WScheduleWIWdrugsWhaveWhighWabuse
WpotentialW andW noWacceptedWmedicalW use.W ScheduleW IIIW drugsWhave W aW less
erWabuseWpotentialWthanWIIWandWanWacceptedWmedicalWuse.WScheduleWIVWdru
gsWhaveWlowWabuseWpotentialWandWlimitedWdependenceWliability.
3.
WhenWinvolvedWinWphaseWIIIWdrugWevaluationWstudies,WwhatWresponsibi
litiesWwouldWtheWnurseWhave?
A) WorkingWwithW animalsW whoW areW givenW experimentalW drugs
B) ChoosingWappropriateW patientsW toWbeWinvolvedW inW theWdrugW study
C) MonitoringWandW observingWpatientsW closelyW forW adverseW effects
D) ConductingW researchW toW determineW effectivenessW ofW theW drug
Ans: C
Feedback:
PhaseWIIIWstudiesWinvolveWuseWofWaWdrugWinWaWvastWclinicalWpopulationWinW
whichWpatientsWareWaskedWtoWrecordWanyWsymptomsWtheyWexperienceWwhileW
takingWtheWdrugs.WNursesWmayWbeWresponsibleWforWhelpingWcollectWandWanal
yzeWtheWinformationWtoWbeWsharedWwithWtheWFoodWandWDrugWAdministratio
nW(FDA)WbutWwouldWnotWconductWresearchWindependentlyWbecauseWnursesWd
oWnotWprescribeWmedications.WUseWofWanimalsWinWdrugWtestingWisWdoneWinWt
heWpreclinicalWtrials.WSelectWpatientsWwhoWareWinvolvedWinWphaseWIIWstudies
WtoWparticipateWinWstudiesWwhereWtheWparticipantsWhaveWtheWdiseaseWtheWdru
gWisWintendedWtoWtreat.WTheseWpatientsWareWmonitoredWcloselyWforWdrugWacti
onWandWadverseWeffects.WPhaseWIWstudiesWinvolveWhealthyWhumanWvolunteer
sWwhoWareWusuallyWpaidWforWtheirWparticipation.WNursesWmayWobserveWforWa
dverseWeffectsWandWtoxicity.
4.
WhatWconceptWisWconsideredWwhenWgenericWdrugsWareWsubstitutedWforW
brandWnameWdrugs?
A) Bioavailability
B) CriticalW concentration
C) Distribution
D) Half-life
Ans: A
Feedback:
PHARMACOLOGY
CLEAR & SIMPLE:
W W
A Guide to Drug Classifications and Dosage Calculations
W W W W W W W
3RD EDITION| By: Cynthia J. Watkins
W W W W W
TEST BANK W
,TestWBank:WPharmacologyWClearWandWSimple:WAWGuideWtoWDrugWClassificationsWa
ndWDosageWCalculationsW3rdWEditionWbyWCynthiaWJ.WWatkins
TableWofWContents:
ChapterW1.WHistoryWofWPharmacology
ChapterW2.WBasicsWofWPharmacology
ChapterW3.WPatientWSafetyWinWMedicationWAdministration
ChapterW4.WRegulations
ChapterW5.WPrescriptionsWandWLabels
II.WCalculations
ChapterW6.WBasicWReviewWofWMathematic
sWChapterW7.WMeasurementWSystemsWCh
apterW8.WDosageWCalculations
ChapterW9.WEnteralWMedicationsWandWAdministration
ChapterW10.WParenteralWMedicationsWandWAdministration
ChapterW11.WIntegumentaryWSystemWMedications
ChapterW12.WMusculoskeletalWSystemWMedications
ChapterW13.WNervousWSystemWMedications
ChapterW14.WEyeWandWEarWMedications
ChapterW15.WEndocrineWSystemWMedications
ChapterW16.WCardiovascularWSystemWMedications
ChapterW17.WImmunologicalWSystemWMedications
ChapterW18.WPulmonaryWSystemWMedications
ChapterW19.WGastrointestinalWSystemWMedications
ChapterW20.WReproductiveWandWUrinaryWSystemsWMedications
ChapterW21.WHerbs,WVitamins,WandWMinerals
,ChapterW1.W HistoryW ofW Pharmacology
PharmacologyWClearWandWSimple-
WAWGuideWtoWDrugWClassificationsWandWDosageWCalculationsW3rdWEditionWWatkinsWTestWBank
1.
AWnurseWworkingWinWradiologyWadministersWiodineWtoWaWpatientWwhoWisWhavingWaco
mputedWtomographyW(CT)Wscan.WTheWnurseWworkingWonWtheWoncologyWunitWadminister
sWchemotherapyWtoWpatientsWwhoWhaveWcancer.WAtWtheWPublicWHealthDepartment,WaWnu
rseWadministersWaWmeasles-mumps-rubellaW(MMR)WvaccineWtoWaW14-month-
oldWchildWasWaWroutineWimmunization.WWhichWbranchWofWpharmacologyWbestWdescribes
WtheWactionsWofWallWthreeWnurses?
A) Pharmacoeconomics
B) Pharmacotherapeutics
C) Pharmacodynamics
D) Pharmacokinetics
Ans: B
Feedback:
PharmacologyWisWtheWstudyWofWtheWbiologicWeffectsWofWchemicals.WNursesWareWinvolve
dWwithWclinicalWpharmacologyWorWpharmacotherapeutics,WwhichWisWaWbranchWofWphar
macologyWthatWdealsWwithWtheWusesWofWdrugsWtoWtreat,Wprevent,WandWdiagnoseWdisease.
WTheWradiologyWnurseWisWadministeringWaWdrugWtoWhelpWdiagnoseWaWdisease.WTheWonco
logyWnurseWisWadministeringWaWdrugWtoWhelpWtreataWdisease.WPharmacoeconomicsWincl
udesWanyWcostsWinvolvedWinWdrugWtherapy.PharmacodynamicsWinvolvesWhowWaWdrugWa
ffectsWtheWbodyWandWpharmacokineticsWisWhowWtheWbodyWactsWonWtheWbody.
2.
AWphysicianWhasWorderedWintramuscularW(IM)WinjectionsWofWmorphine,WaW
narcotic,WeveryW4WhoursWasWneededWforWpainWinWaWmotorWvehicleWaccidentW
victim.WTheWnurseWisWawareWthisWdrugWhasWaWhighWabuseWpotential.WUnderW
whatWcategoryWwouldWmorphineWbeWclassified?
A) ScheduleWI
B) ScheduleWII
C) ScheduleWIII
D) ScheduleWIV
Ans: B
, Feedback:
NarcoticsWwithWaWhighWabuseWpotentialWareWclassifiedWasWScheduleWIIWdrugsW
becauseWofWsevereWdependenceWliability.WScheduleWIWdrugsWhaveWhighWabuse
WpotentialW andW noWacceptedWmedicalW use.W ScheduleW IIIW drugsWhave W aW less
erWabuseWpotentialWthanWIIWandWanWacceptedWmedicalWuse.WScheduleWIVWdru
gsWhaveWlowWabuseWpotentialWandWlimitedWdependenceWliability.
3.
WhenWinvolvedWinWphaseWIIIWdrugWevaluationWstudies,WwhatWresponsibi
litiesWwouldWtheWnurseWhave?
A) WorkingWwithW animalsW whoW areW givenW experimentalW drugs
B) ChoosingWappropriateW patientsW toWbeWinvolvedW inW theWdrugW study
C) MonitoringWandW observingWpatientsW closelyW forW adverseW effects
D) ConductingW researchW toW determineW effectivenessW ofW theW drug
Ans: C
Feedback:
PhaseWIIIWstudiesWinvolveWuseWofWaWdrugWinWaWvastWclinicalWpopulationWinW
whichWpatientsWareWaskedWtoWrecordWanyWsymptomsWtheyWexperienceWwhileW
takingWtheWdrugs.WNursesWmayWbeWresponsibleWforWhelpingWcollectWandWanal
yzeWtheWinformationWtoWbeWsharedWwithWtheWFoodWandWDrugWAdministratio
nW(FDA)WbutWwouldWnotWconductWresearchWindependentlyWbecauseWnursesWd
oWnotWprescribeWmedications.WUseWofWanimalsWinWdrugWtestingWisWdoneWinWt
heWpreclinicalWtrials.WSelectWpatientsWwhoWareWinvolvedWinWphaseWIIWstudies
WtoWparticipateWinWstudiesWwhereWtheWparticipantsWhaveWtheWdiseaseWtheWdru
gWisWintendedWtoWtreat.WTheseWpatientsWareWmonitoredWcloselyWforWdrugWacti
onWandWadverseWeffects.WPhaseWIWstudiesWinvolveWhealthyWhumanWvolunteer
sWwhoWareWusuallyWpaidWforWtheirWparticipation.WNursesWmayWobserveWforWa
dverseWeffectsWandWtoxicity.
4.
WhatWconceptWisWconsideredWwhenWgenericWdrugsWareWsubstitutedWforW
brandWnameWdrugs?
A) Bioavailability
B) CriticalW concentration
C) Distribution
D) Half-life
Ans: A
Feedback:
